CLOCK genes and circadian rhythmicity in Alzheimer disease

Journal of Aging Research

Volumn 2011, Issue , 2011, Pages

  Thome, J ^a   Coogan, A N ^b   Woods, A G ^c   Darie, C C ^c   Hassler F ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c CLARKSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BMAL1; RNA; TAU PROTEIN; TRANSCRIPTION FACTOR CLOCK; VASOPRESSIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CIRCADIAN RHYTHM; CLOCK GENE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHOTOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEEP DISORDER; SLEEP QUALITY;

EID: 84867335855     PISSN: 20902204     EISSN: 20902212     Source Type: Journal    
DOI: 10.4061/2011/383091     Document Type: Article

References (39)

1. Barnes D. E., Yaffe K., The projected effect of risk factor reduction on Alzheimer's disease prevalence. The Lancet Neurology 2011 10 9 819 828 10.1016/S1474-4422(11)70072-2
2. Alzheimer A., Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und psychisch-gerichtliche Medizin 1907 64 146 148
3. Bettens K., Sleegers K., van Broeckhoven C., Current status on alzheimer disease molecular genetics: from past, to present, to future. Human Molecular Genetics 2010 19 1 R4 R11 2-s2.0-77953886784 10.1093/hmg/ddq142 ddq142
4. Retz W., Thome J., Durany N., Harsányi A., Retz-Junginger P., Kornhuber J., Riederer P., Rösler M., Potential genetic markers of sporadic Alzheimer's dementia. Psychiatric Genetics 2001 11 3 115 122 2-s2.0-0034776045 10.1097/00041444-200109000-00002 (Pubitemid 32980610)
5. Rahmadi A., Steiner N, Münch G., Advanced glycation enproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease. Clinical Chemistry and Laboratory Medicine 2011 49 385 391
6. Thome J., Rösler M., John M., Sakai N., Riederer P., Muench G., Advanced glycatopn endproduct (AGE) inhibition as possible pharmacotherapeutic strategy in the treatmentof Alzheimer's dementia. Drugs of the Future, pp., 1999 24 4 411 416 10.1358/dof.1999.024.04.660936 (Pubitemid 29266178)
7. Yankner B. A., Lu T., Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. Journal of Biological Chemistry 2009 284 8 4755 4759 2-s2.0-64149132721 10.1074/jbc.R800018200
8. Iqbal K., Grundke-Iqbal I., Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. Journal of Cellular and Molecular Medicine 2008 12 1 38 55 2-s2.0-41149156856 10.1111/j.1582-4934. 2008.00225.x (Pubitemid 351436349)
9. van Broeck B., van Broeckhoven C., Kumar-Singh S., Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches. Neurodegenerative Diseases 2007 4 5 349 365 2-s2.0-34547173081 10.1159/000105156 (Pubitemid 47123462)
10. Emery V. O., Alzheimer disease: are we intervening too late? Journal of Neural Transmission 2011 118 9 1361 1378
11. Harper D. G., Stopa E. G., McKee A. C., Satlin A., Fish D., Volicer L., Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease. Neurobiology of Aging 2004 25 6 771 781 2-s2.0-2542606051 10.1016/j. neurobiolaging.2003.04.009 (Pubitemid 38701767)
12. Harper D. G., Stopa E. G., McKee A. C., Satlin A., Harlan P. C., Goldstein R., Volicer L., Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Archives of General Psychiatry 2001 58 4 353 360 2-s2.0-0035051332 (Pubitemid 32303191)
13. Harper D. G., Volicer L., Stopa E. G., McKee A. C., Nitta M., Satlin A., Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. American Journal of Geriatric Psychiatry 2005 13 5 359 368 2-s2.0-18144398609 10.1176/appi.ajgp.13.5.359 (Pubitemid 40617478)
14. Yesavage J. A., yesavage@stanford.edu Noda A., Hernandez B., Friedman L., Cheng J. J., Tinklenberg J. R., Hallmayer J., O'Hara R., David R., Robert P., Landsverk E., Zeitzer J. M., Circadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer disease. American Journal of Geriatric Psychiatry 2011 19 7 635 643 10.1097/JGP.0b013e31820d92b2
15. Coogan A. N., Thome J., Chronotherapeutics and psychiatry: setting the clock to relieve the symptoms. World Journal of Biological Psychiatry 2011 12, supplement 1 40 43
16. Franken P., Dijk D. J., Circadian clock genes and sleep homeostasis. European Journal of Neuroscience 2009 29 9 1820 1829 2-s2.0-65549129703 10.1111/j.1460-9568.2009.06723.x
17. Coogan A. N., Papachatzaki M. M., Clemens C., Haloperidol alters circadian clock gene product expression in the mouse brain. World Journal of Biological Psychiatry. In press
18. Wulff K., Gatti S., Wettstein J. G., Foster R. G., Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nature Reviews Neuroscience 2010 11 8 589 599 2-s2.0-77954887739 10.1038/nrn2868
19. Bliwise D. L., Mercaldo N. D., Avidan A. Y., Boeve B. F., Greer S. A., Kukull W. A., Sleep disturbance in dementia with Lewy bodies and Alzheimer's disease: amulticenter analysis. Dementia and Geriatric Cognitive Disorders 2011 31 3 239 246
20. Song Y., Dowling G. A., Wallhagen M. I., Lee K. A., Strawbridge W. J., Sleep in older adults with Alzheimer's disease. Journal of Neuroscience Nursing 2010 42 4 190 198 2-s2.0-77956916402 10.1097/JNN.0b013e3181e26b1d
21. Mulin E., mulin.e@chu-nice.fr Zeitzer J. M., Friedman L., Le Duff F., Yesavage J., Robert P. H., David R., Relationship between apathy and sleep disturbance in mild and moderate Alzheimer's disease: an actigraphic study. Journal of Alzheimer's Disease 2011 25 1 85 91 10.3233/JAD-2011-101701
22. Creese J., Bédard M., Brazil K., Chambers L., Sleep disturbances in spousal caregivers of individuals with Alzheimer's disease. International Psychogeriatrics 2008 20 1 149 161 2-s2.0-37149023803 10.1017/S1041610207005339 (Pubitemid 350256055)
23. Hatfield C. F., Herbert J., van Someren E. J. W., Hodges J. R., Hastings M. H., Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain 2004 127 5 1061 1074 2-s2.0-2442502760 10.1093/brain/awh129 (Pubitemid 38623042)
24. Hu K., van Someren E. J. W., Shea S. A., Scheer F. A. J. L., Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: involvement of the circadian pacemaker. Proceedings of the National Academy of Sciences of the United States of America 2009 106 8 2490 2494 2-s2.0-62449216579 10.1073/pnas.0806087106
25. Stopa E. G., Volicer L., Kuo-Leblanc V., Harper D., Lathi D., Tate B., Satlin A., Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. Journal of Neuropathology and Experimental Neurology 1999 58 1 29 39 2-s2.0-0032920750 (Pubitemid 29053023)
26. Zhou J. N., Hofman M. A., Swaab D. F., VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiology of Aging 1995 16 4 571 576 2-s2.0-0029121750 10.1016/0197-4580(95)00043-E
27. Bachman D., Rabins P., 'Sundowning' and other temporally associated agitation states in dementia patients. Annual Review of Medicine 2006 57 499 511 2-s2.0-32944454301 10.1146/annurev.med.57.071604.141451 (Pubitemid 43262004)
28. Tate B., Aboody-Guterman K. S., Morris A. M., Walcott E. C., Majocha R. E., Marotta C. A., Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid. Proceedings of the National Academy of Sciences of the United States of America 1992 89 15 7090 7094 2-s2.0-0026693119 10.1073/pnas.89.15.7090
29. Sterniczuk R., Dyck R. H., Laferla F. M., Antle M. C., Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes. Brain Research 2010 1348 139 148 2-s2.0-77955714612 10.1016/j.brainres.2010.05. 013
30. Bero A. W., Yan P., Roh J. H., Neuronal activity regulates the regional vulnerability to amyloid-b deposition. Nature Neuroscience 2011 14 750 756 10.1038/nn.2801
31. Craig D., Hart D. J., Passmore A. P., Genetically increased risk of sleep disruption in Alzheimer's disease. Sleep 2006 29 8 1003 1007 2-s2.0-33747479175 (Pubitemid 44257376)
32. Kissling C., Retz W., Wiemann S., Coogan A. N., Clement R. M., Hünnerkopf R., Conner A. C., Freitag C. M., Rösler M., Thome J., A polymorphism at the 3 ′ -untranslated region of the CLOCK gene is associated with adult attention-deficit hyperactivity disorder. American Journal of Medical Genetics Part B 2008 147 3 333 338 2-s2.0-42149184132 10.1002/ajmg.b.30602 (Pubitemid 351536797)
33. Cermakian N., nicolas.cermakian@mcgill.ca Lamont E. W., Boudreau P., Boivin D. B., Circadian clock gene expression in brain regions of Alzheimer's disease patients and control subjects. Journal of Biological Rhythms 2011 26 2 160 170 10.1177/0748730410395732
34. Beynon A. L., Thome J., Coogan A. N., Age and time of day influences on the expression of transforming growth factor-beta and phosphorylated SMAD3 in the mouse suprachiasmatic and paraventricular nuclei. NeuroImmunoModulation 2009 16 6 392 399 2-s2.0-67650468169 10.1159/000228914
35. Liu R. Y., Zhou J. N., Hoogendijk W. J. G., Van Heerikhuize J., Kamphorst W., Unmehopa U. A., Hofman M. A., Swaab D. F., Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. Journal of Neuropathology and Experimental Neurology 2000 59 4 314 322 2-s2.0-0034033920 (Pubitemid 30183699)
36. Rosenwasser A. M., Circadian clock genes: non-circadian roles in sleep, addiction, and psychiatric disorders? Neuroscience and Biobehavioral Reviews 2010 34 8 1249 1255 2-s2.0-77954083602 10.1016/j.neubiorev.2010.03.004
37. Most E. I. S., Scheltens P., van Someren E. J. W., Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light-a randomized clinical trial. Trials 2010 11, article 19 2-s2.0-77649312978 10.1186/1745-6215-11-19
38. Riemersma-van der Lek R. F., Swaab D. F., Twisk J., Hol E. M., Hoogendijk W. J. G., Van Someren E. J. W., Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA-Journal of the American Medical Association 2008 299 22 2642 2655 2-s2.0-44949175084 10.1001/jama.299.22.2642 (Pubitemid 351831594)
39. Wirz-Justice A., Werth E., Savaskan E., Knoblauch V., Gasio P. F., Müller-Spahn F., Haloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer disease. Alzheimer Disease and Associated Disorders 2000 14 4 212 215 2-s2.0-0033667727 10.1097/00002093-200010000-00005